
Tuesday, October 15, 2024 12:56:38 AM
Shum statement…….“We are confident that our expanded portfolio business model and combined assets have the potential to create significant value for both legacy and new shareholders,” Shum says in the statement.“
There is ZERO value in fertility banks or whatever the hell you are pushing with that brick and mortar shit. Wake up people. The business expansion weighs on each US state and their current laws. Maybe they bring over to Europe and Asia. Still dumbest concept for Pharma. You are talking about a small percentage customer base. Too small I would fire every last one of you just for entertaining that avenue. Pharma should only be wanting to push drugs and the gene and cell editing side of things. This venture to me is you building the cap table for me and other like minded folk. Big period. So keep up your bullshit games but you better change the channel soon cause this fertility game show is weak at best and is making me damn tired. Hurry the fuck up with ESHA, Satellos, Immunis etc. Get off of Sharon Barr, and focus on making us our money. And please shut the fuck up. Your breath stinks like shit. Hula Hula Cuckoo Penny
Recent INVO News
- NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma • GlobeNewswire Inc. • 10/24/2024 01:00:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 10/22/2024 04:05:35 PM
- INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences • GlobeNewswire Inc. • 10/21/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:17:59 PM
- INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) • GlobeNewswire Inc. • 10/14/2024 01:18:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 09:26:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:06:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 01:00:36 PM
- INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA • GlobeNewswire Inc. • 08/14/2024 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/21/2024 08:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:51:16 PM
- INVO Reports Record First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:30:18 PM
- Micro Cap Massively Bid Up Before Opening Bell • AllPennyStocks.com • 04/17/2024 02:25:00 PM
- INVO Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/16/2024 08:59:29 PM
FEATURED Hivello Token ($HVLO) now Live • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM